NEXUS Epigenomics AB is a Swedish biotech company developing scalable, enzyme-based technologies for genome-wide epigenomic profiling. Its lead platform, MeTLAND® captures high-quality methylated DNA from low-input and clinically relevant samples. The company is a spinout from research conducted at the Karolinska Institute and Stockholm University, and is supported with funding from the European Research Council, KI Innovations, SU Innovations, and Sweden’s largest bank, SEB.

NEXUS Epigenomics

Org chart

Teams

Offices